StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Japanese Hep C Boosts Gilead Sciences (GILD) in the Qtr - Baird
February 3, 2016 7:20 AM
Baird analyst Brian Skorney reiterated an Outperform rating and $135 price target on Gilead Sciences (NASDAQ: GILD) following Q4 results ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Next Articles
Gilead (GILD) Needs Impactful M&A for the Next Leg of Growth - Piper Jaffray
February 3, 2016 9:11 AM
Gilead's (GILD) Increased Unit Sales Tempered By Lower Prices - Oppenheimer
February 3, 2016 7:11 AM
Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; Adds $12B to Stock Buyback Plan
February 2, 2016 4:03 PM
Gilead Sciences Announces Declaration of Q1 Cash Dividend and Increases to Shareholder Return Programs
February 2, 2016 4:01 PM
Gilead Sciences (GILD) Tops Q4 EPS by 32c
February 2, 2016 4:00 PM
Gilead Sciences Announces Fourth Quarter and Full Year 2015 Financial Results
February 2, 2016 4:00 PM
